HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
L Spelman Selected Research
L Spelman Research Topics
Disease
3
Psoriasis (Pustulosis Palmaris et Plantaris)
02/2022 - 12/2017
3
Atopic Dermatitis (Atopic Eczema)
01/2021 - 01/2016
3
Actinic Keratosis
11/2014 - 06/2003
2
Inflammation (Inflammations)
01/2021 - 01/2016
1
Eczema
01/2021
1
Headache (Headaches)
01/2020
1
Nasopharyngitis
01/2020
1
Venous Thromboembolism
01/2020
1
Disease Progression
01/2016
1
Pain (Aches)
11/2014
1
Eosinophilia-Myalgia Syndrome
06/2006
1
Eosinophilic Fasciitis
06/2006
1
Basal Cell Carcinoma (Rodent Ulcer)
04/2005
Drug/Important Bio-Agent (IBA)
3
methyl 5-aminolevulinate
IBA
05/2008 - 06/2003
2
1-phenyl-3,3-dimethyltriazene (PDT)
IBA
11/2014 - 05/2008
1
tildrakizumab
IBA
02/2022
1
Cytokines
IBA
01/2021
1
tralokinumab
IBA
01/2021
1
Interleukin-13
IBA
01/2021
1
Immunoglobulin A (IgA)
IBA
01/2021
1
Monoclonal Antibodies
IBA
01/2021
1
baricitinib
IBA
01/2020
1
ixekizumab
IBA
01/2020
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2020
1
Janus Kinase 1
IBA
01/2020
1
ABP 501
IBA
12/2017
1
Adalimumab (Humira)
FDA Link
12/2017
1
Biosimilar Pharmaceuticals
IBA
12/2017
1
Type 4 Cyclic Nucleotide Phosphodiesterases
IBA
01/2016
1
crisaborole
IBA
01/2016
1
Kynurenine
IBA
06/2006
1
Tryptophan (L-Tryptophan)
FDA Link
06/2006
1
Quinolinic Acid
IBA
06/2006
Therapy/Procedure
4
Photochemotherapy (Photodynamic Therapy)
11/2014 - 06/2003
2
Cryotherapy (Therapy, Cold)
05/2008 - 06/2003